Moreover, A&D Pharma contracted a syndicated loan of EUR190 million to fund its operational and development needs, the parties involved in the deal, the biggest of its kind on the Romanian pharmaceutical market in 2013, said in a press release Wednesday.

BCR, BRD, and UniCredit Tiriac Bank contributed equally to the financing.